Effectiveness of secukinumab versus an alternative TNF inhibitor in patients with axial spondyloarthritis previously exposed to TNF inhibitors in the Swiss Clinical Quality Management cohort
Raphael Micheroli, Christoph Tellenbach, Almut Scherer, Kristina Bürki, Karin Niederman, Michael J. Nissen, Pascal Zufferey, Pascale Exer, Burkhard Möller, Diego Kyburz, Adrian Ciurea
Topics & Concepts
MedicineAnkylosing spondylitisSecukinumabDiscontinuationBASDAIInternal medicineCohortPropensity score matchingTNF inhibitorProportional hazards modelInfliximabTumor necrosis factor alphaRheumatoid arthritisPsoriatic arthritisSpondyloarthritis Studies and TreatmentsRheumatoid Arthritis Research and TherapiesInterstitial Lung Diseases and Idiopathic Pulmonary Fibrosis